Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC has seen some interesting run up the past few days.

<< Previous

Bullboard Posts

Next >>

Comment by Kswdeluxon Apr 08, 2021 11:24am

255 Views

Post# 32956667

RE:RE:RE:RE:RE:RE:RE:ONC has seen some interesting run up the past few days.

No, don't sell shares Fri, I was refering to watching what happens on the 12th and make a call then.
.

but since my original comment, ONC has announced the April 15 Canacord meeting with additionally one to one investor meeting. That is very integuing. The oneto one investing meeting has my attention now.

My thoughts on that are... it seems ONC may actually have so ething significant to talk about this time.

Maybe we are finally headed over $10

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management